Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ingmar
Ingmar Alderberg, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20090248375 | Centralised stochastic simulation process - A method of simulating a local system which is in interaction with other local systems within a global environment. The method includes generating, at a central location, a collection of global sets of values, each representing a possible future global state of the global environment at a future time, and the collection representing a variety of possible future global states. The method also includes transmitting the collection of global sets of values to the local systems. The local systems receive some of the collection, select a local set of parameters, and perform calculations on that data. The collection of values is used as a predictive simulation of the local system. | 10-01-2009 |
Ingmar Andersson, Linkoping SE
| Patent application number | Description | Published |
|---|---|---|
| 20110019904 | METHOD FOR DISPLAYING A VIRTUAL IMAGE - A method for displaying a virtual image of three dimensional objects in an area using stereo recordings of the area for storing a pixel and a height for each point of the area. A method is obtained of enabling displaying of vertical surfaces or even slightly downwards and inwards inclined surfaces. Stereo recordings from at least three different stereo recordings of different solid angles are used. For each different solid angle at least one data base including data about texture and height pixel point wise is established. Data for displaying the virtual image are combined from the different data bases in dependence of the direction in which the virtual image is to be displayed. | 01-27-2011 |
Ingmar Barthold, Salach DE
| Patent application number | Description | Published |
|---|---|---|
| 20110236276 | ANALYTICAL TEST TAPE INSTRUMENT - An analytical test tape instrument includes an exchangeable test tape unit which comprises a test tape provided with a plurality of test elements to which body fluid can be applied. The test tape instrument also includes a tape drive that can be coupled with the test tape unit to wind the test tape so that the test elements can be successively made available at an application site. The tape drive has a direct current motor and a reduction gear unit arranged between the direct current motor and the test tape unit. | 09-29-2011 |
Ingmar Bergbohm, Dusseldorf DE
| Patent application number | Description | Published |
|---|---|---|
| 20120055945 | CLOSURE-SEALING SYSTEM FOR ROTATIONAL OPENING - The invention relates to a closure system for a container comprising a closure and container opening portion. The closure releasably seals the container opening and has a cylindrical collar comprising a plurality of elastically designed tabs. The free ends of the tabs deflect radially and comprise latching elements on at least one part At least one radially extending holding element is molded on the enveloping surface of the container and forms a snap-in connection with the latching elements. A plurality of guidance elements interact with the tabs and latching elements such that upon rotation of the closure in an opening direction, a spreading of the tabs radially releases the snap-in connection. | 03-08-2012 |
Ingmar Hoerr, Tuebingen DE
| Patent application number | Description | Published |
|---|---|---|
| 20120009221 | TRANSFECTION OF BLOOD CELLS WITH MRNA FOR IMMUNE STIMULATION AND GENE THERAPY - The present invention relates to a pharmaceutical composition containing blood cells or haemopoietic cells, e.g. red blood cells (erythrocytes), granulocytes, mononuclear cells (PBMCs) and/or blood platelets, in combination with a pharmaceutically acceptable excipient and/or vehicle, wherein the cells are transfected with at least one mRNA comprising at least one region coding for at least one antigen. The invention further discloses a method of preparing the aforesaid pharmaceutical composition and the use of blood cells transfected in this way for the preparation of drugs or pharmaceutical compositions for immune stimulation against the antigens encoded by the mRNA. The subjects according to the invention are used especially for the therapy and/or prophylaxis of carcinoses or infectious diseases and can also be employed in gene therapy. | 01-12-2012 |
Ingmar Hogoy, Storebo NO
| Patent application number | Description | Published |
|---|---|---|
| 20110168100 | Method of feeding aquatic organisms - A method of feeding aquatic organisms with an artificial food. The food is in the form of microcapsules having an outer permeable polymeric shell of chitosan or alginate and an inner core of liquid food for the aquatic organism. The method involves introducing the microcapsules into an aquatic environment where they are available to be consumed by the organism. The shells of the microcapsules consist of a single polymer, the liquid food has a dry matter content comprising water-soluble, hydrolyzed proteins, peptides and amino acids, and the capsules are arranged to leak the liquid food into the aquatic environment through the shell such that at least 40% of the dry matter content remains in the capsules once the leakage has substantially ceased. | 07-14-2011 |
Ingmar Kallfass, Strasbourg FR
| Patent application number | Description | Published |
|---|---|---|
| 20090215406 | TRANSCEIVER STRUCTURE - The present invention relates to an integrated transceiver structure | 08-27-2009 |
| 20120025920 | Oscillator with Ohmically Adjustable Oscillation Frequency - An oscillator with adjustable oscillation frequency includes an active device showing a negative input resistance at a terminal, an oscillator circuit coupled to the terminal of the active device showing the negative input resistance, and an element with adjustable ohmic resistance by which the oscillation frequency of the oscillator is adjustable. | 02-02-2012 |
Ingmar Rathe, Olching DE
| Patent application number | Description | Published |
|---|---|---|
| 20090017536 | MODIFIED VACCINIA ANKARA VIRUS VARIANT AND CULTIVATION METHOD - The present invention provides an attenuated virus, which is derived from Modified Vaccinia Ankara virus and characterized by the loss of its capability to reproductively replicate in human cell lines. It further describes recombinant viruses derived from this virus and the use of the virus, or its recombinants, as a medicament or vaccine. A method is provided for inducing an immune response in individuals who may be immune-compromised, receiving antiviral therapy, or have a pre-existing immunity to the vaccine virus. In addition, a method is provided for the administration of a therapeutically effective amount of the virus, or its recombinants, in a vaccinia virus prime/vaccinia virus boost inoculation regimen. The present invention relates to a method of virus amplification in primary cells which are cultivated in a serum free medium. Viruses produced by this method are advantageously free of any infectious agents comprised in animal sera. | 01-15-2009 |
| 20090029459 | METHOD FOR THE CULTIVATION OF PRIMARY CELLS AND FOR THE AMPLIFICATION OF VIRUSES UNDER SERUM FREE CONDITIONS - The present invention relates to a method for the cultivation of primary cells. The primary cells are cultivated in a serum free medium comprising a factor selected from the group consisting of growth factors and attachment factors. The method for the cultivation of primary cells may be one step in a method for the amplification of viruses, such as poxviruses. According to this latter method the primary cells are cultivated in a serum free medium comprising a factor selected from the group consisting of growth factors and attachment factors. The cells are then infected with the virus and the infected cells are cultivated in serum free medium until progeny virus is produced. | 01-29-2009 |
| 20100279386 | MODIFIED VACCINIA ANKARA VIRUS VARIANT AND CULTIVATION METHOD - The present invention provides an attenuated virus, which is derived from Modified Vaccinia Ankara virus and characterized by the loss of its capability to reproductively replicate in human cell lines. It further describes recombinant viruses derived from this virus and the use of the virus, or its recombinants, as a medicament or vaccine. A method is provided for inducing an immune response in individuals who may be immune-compromised, receiving antiviral therapy, or have a pre-existing immunity to the vaccine virus. In addition, a method is provided for the administration of a therapeutically effective amount of the virus, or its recombinants, in a vaccinia virus prime/vaccinia virus boost innoculation regimen. The present invention relates to a method of virus amplification in primary cells which are cultivated in a serum free medium. Viruses produced by this method are advantageously free of any infectious agents comprised in animal sera. | 11-04-2010 |
| 20110217749 | METHOD FOR THE CULTIVATION OF PRIMARY CELLS AND FOR THE AMPLIFICATION OF VIRUSES UNDER SERUM FREE CONDITIONS - The present invention relates to a method for the cultivation of primary cells. The primary cells are cultivated in a serum free medium comprising a factor selected from the group consisting of growth factors and attachment factors. | 09-08-2011 |
| 20110217757 | MODIFIED VACCINIA ANKARA VIRUS VARIANT AND CULTIVATION METHOD - The present invention provides an attenuated virus, which is derived from Modified Vaccinia Ankara virus and characterized by the loss of its capability to reproductively replicate in human cell lines. It further describes recombinant viruses derived from this virus and the use of the virus, or its recombinants, as a medicament or vaccine. A method is provided for inducing an immune response in individuals who may be immune-compromised, receiving antiviral therapy, or have a pre-existing immunity to the vaccine virus. In addition, a method is provided for the administration of a therapeutically effective amount of the virus, or its recombinants, in a vaccinia virus prime/vaccinia virus boost inoculation regimen. The present invention relates to a method of virus amplification in primary cells which are cultivated in a serum free medium. Viruses produced by this method are advantageously free of any infectious agents comprised in animal sera. | 09-08-2011 |
Ingmar Rathe US
| Patent application number | Description | Published |
|---|---|---|
| 20080317778 | MODIFIED VACCINIA ANKARA VIRUS VARIANT AND CULTIVATION METHOD - The present invention provides an attenuated virus, which is derived from Modified Vaccinia Ankara virus and characterized by the loss of its capability to reproductively replicate in human cell lines. It further describes recombinant viruses derived from this virus and the use of the virus, or its recombinants, as a medicament or vaccine. A method is provided for inducing an immune response in individuals who may be immune-compromised, receiving antiviral therapy, or have a pre-existing immunity to the vaccine virus. In addition, a method is provided for the administration of a therapeutically effective amount of the virus, or its recombinants, in a vaccinia virus prime/vaccinia virus boost inoculation regimen. The present invention relates to a method of virus amplification in primary cells which are cultivated in a serum free medium. Viruses produced by this method are advantageously free of any infectious agents comprised in animal sera. | 12-25-2008 |
Ingmar Stuns, Espoo FI
| Patent application number | Description | Published |
|---|---|---|
| 20090269767 | MICROFLUIDIC CHIP DEVICES AND THEIR USE - A microfluidic chip device (MCD) and its use for performing miniaturized assays on magnetic microbeads (MMs) are described. The MCD is particularly useful for carrying out miniaturized transcript analysis by aiding affinity capturing (TRAC) assays, including PCR. The MCD comprises at least one reaction chamber with sealable liquid connections and at least one fluidic pillar filter in each chamber. The fluidic pillar filter comprises rods with spacings allowing MMs to pass. The sealable liquid connections feed liquid to the reaction chamber, wherein air bubbles are removed. The liquid stream contacts the MMs, which are manipulated with a magnetic rod. The liquid connections enable trapping of the MMs behind the pillar filters or in the channel, while the liquid is changed. | 10-29-2009 |
Ingmar Theimann, Munich DE
| Patent application number | Description | Published |
|---|---|---|
| 20080200808 | DISPLAYING ANATOMICAL PATIENT STRUCTURES IN A REGION OF INTEREST OF AN IMAGE DETECTION APPARATUS - A method and device for detecting and displaying an anatomical patient structure in a region of interest of a movable image detection apparatus such as an ultrasound probe. After the region of interest is defined in a patient coordinate system, movement of the image detection apparatus can be tracked, and the position of the region of interest can be changed or shifted to compensate for the movement of the image detection apparatus. | 08-21-2008 |
Ingmar Tiehmann, Munich DE
| Patent application number | Description | Published |
|---|---|---|
| 20100177185 | SURGICAL MICROSCOPE WITH INTEGRATED STRUCTURED ILLUMINATION - The application concerns a method of integrating image information ( | 07-15-2010 |